Robeco Institutional Asset Management’s Emergent Biosolutions EBS Stock Holding History

Robeco Institutional Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-33,696	Closed	-$398K	–	1047
2022 Q4	$398K	Buy	+33,696	New	+$521K	﹤0.01%	865
2019 Q2	–	Sell	-8,562	Closed	-$433K	–	973
2019 Q1	$433K	Hold	8,562	–	–	﹤0.01%	852
2018 Q4	$508K	Sell	8,562 -526	-6%	-$33.9K	﹤0.01%	811
2018 Q3	$599K	Hold	9,088	–	–	﹤0.01%	811
2018 Q2	$459K	Buy	9,088 +7,624	+521%	+$397K	﹤0.01%	822
2018 Q1	$77K	Buy	+1,464	New	+$73K	﹤0.01%	921

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Robeco Institutional Asset Management's EBS Position: Q1 2023 in Review

Robeco Institutional Asset Management sold out of Emergent Biosolutions (EBS) in Q1 2023, closing a stake of 33,696 shares — an estimated $398K sold.

Robeco Institutional Asset Management first reported a position in EBS in Q1 2018 and held it in 6 quarters. The position peaked at $599K in Q3 2018. 189 funds tracked by Wall St. Rank hold EBS as of Q1 2023.

Robeco Institutional Asset Management reported no remaining Emergent Biosolutions position as of Q1 2023 after selling out during the quarter.
Robeco Institutional Asset Management sold 33,696 Emergent Biosolutions shares in Q1 2023, an estimated $398K.
Robeco Institutional Asset Management first reported a position in Emergent Biosolutions in Q1 2018 and held it in 6 quarters.
Robeco Institutional Asset Management's Emergent Biosolutions position peaked at $599K in Q3 2018.
189 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2023.

Based on Robeco Institutional Asset Management's 13F filing for Q1 2023, filed 4 May 2023.